PolyPid Ltd. – NASDAQ:PYPD
PolyPid Ltd. stock price today
$3.53
+0.63
+22.15%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 9 hours
PolyPid Ltd. stock price monthly change
-23.75%
month
PolyPid Ltd. stock price quarterly change
-23.75%
quarter
PolyPid Ltd. stock price yearly change
-27.75%
year
PolyPid Ltd. key metrics
Market Cap | 23.87M |
Enterprise value | 13.43M |
P/E | -0.22 |
EV/Sales | N/A |
EV/EBITDA | -0.33 |
Price/Sales | N/A |
Price/Book | 1.40 |
PEG ratio | -0.03 |
EPS | -12.55 |
Revenue | N/A |
EBITDA | -23.38M |
Income | -24.24M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freePolyPid Ltd. stock price history
PolyPid Ltd. stock forecast
PolyPid Ltd. financial statements
Average Price Target
$10
Potential upside: 183.28%
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 0 | -5.83M | |
|---|---|---|---|
| Sep 2023 | 0 | -5.60M | |
| Dec 2023 | 0 | -6.35M | |
| Mar 2024 | 0 | -6.44M |
| Jun 2023 | 26263000 | 17.91M | 68.22% |
|---|---|---|---|
| Sep 2023 | 20932000 | 17.39M | 83.1% |
| Dec 2023 | 15372000 | 17.46M | 113.64% |
| Mar 2024 | 25395000 | 18.25M | 71.86% |
| Mar 2023 | 0 | 0 | 0 |
|---|---|---|---|
| Jun 2023 | 0 | 0 | 0 |
| Sep 2023 | 0 | 0 | 0 |
| Dec 2023 | 0 | 0 | 0 |
PolyPid Ltd. alternative data
| Aug 2023 | 57 |
|---|---|
| Sep 2023 | 57 |
| Oct 2023 | 57 |
| Nov 2023 | 57 |
| Dec 2023 | 57 |
| Jan 2024 | 57 |
| Feb 2024 | 57 |
| Mar 2024 | 59 |
| Apr 2024 | 59 |
| May 2024 | 59 |
| Jun 2024 | 59 |
| Jul 2024 | 59 |
PolyPid Ltd. other data
0.51%
-1.44%
of PYPD is owned by hedge funds
98.55K
-281.92K
shares is hold by hedge funds
| Patent |
|---|
Application Filling date: 2 Jun 2020 Issue date: 17 Sep 2020 |
Grant Filling date: 27 Sep 2015 Issue date: 1 Sep 2020 |
Application Filling date: 13 Feb 2020 Issue date: 27 Aug 2020 |
Grant Filling date: 6 Sep 2018 Issue date: 16 Jun 2020 |
Grant Filling date: 17 Feb 2015 Issue date: 5 Nov 2019 |
| Quarter | Transcript |
|---|---|
| Q1 2024 8 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 14 Feb 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 12 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 9 Aug 2023 | Q2 2023 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
Mr. Amir Weisberg (1956) Chief Executive Officer & Director | $936,620 |
Dr. Noam Emanuel (1959) Chief Scientific Officer | $804,820 |
Ms. Dikla Czaczkes Akselbrad (1973) Executive Vice President & Chief Financial Officer | $565,170 |
Ms. Dalit Hazan (1971) Vice President of R&D and Regulatory Affairs | $232,950 |
-
What's the price of PolyPid Ltd. stock today?
One share of PolyPid Ltd. stock can currently be purchased for approximately $3.53.
-
When is PolyPid Ltd.'s next earnings date?
Unfortunately, PolyPid Ltd.'s (PYPD) next earnings date is currently unknown.
-
Does PolyPid Ltd. pay dividends?
No, PolyPid Ltd. does not pay dividends.
-
How much money does PolyPid Ltd. make?
PolyPid Ltd. has a market capitalization of 23.87M.
-
What is PolyPid Ltd.'s stock symbol?
PolyPid Ltd. is traded on the NASDAQ under the ticker symbol "PYPD".
-
What is PolyPid Ltd.'s primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of PolyPid Ltd.?
Shares of PolyPid Ltd. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are PolyPid Ltd.'s key executives?
PolyPid Ltd.'s management team includes the following people:
- Mr. Amir Weisberg Chief Executive Officer & Director(age: 69, pay: $936,620)
- Dr. Noam Emanuel Chief Scientific Officer(age: 66, pay: $804,820)
- Ms. Dikla Czaczkes Akselbrad Executive Vice President & Chief Financial Officer(age: 52, pay: $565,170)
- Ms. Dalit Hazan Vice President of R&D and Regulatory Affairs(age: 54, pay: $232,950)
-
How many employees does PolyPid Ltd. have?
As Jul 2024, PolyPid Ltd. employs 59 workers.
-
When PolyPid Ltd. went public?
PolyPid Ltd. is publicly traded company for more then 5 years since IPO on 26 Jun 2020.
-
What is PolyPid Ltd.'s official website?
The official website for PolyPid Ltd. is polypid.com.
-
How can i contact PolyPid Ltd.?
PolyPid Ltd. can be reached via phone at +972 74 719 5700.
-
What is PolyPid Ltd. stock forecast & price target?
Based on 1 Wall Street analysts` predicted price targets for PolyPid Ltd. in the last 12 months, the avarage price target is $10. The average price target represents a 183.28% change from the last price of $3.53.
PolyPid Ltd. company profile:
PolyPid Ltd.
polypid.comExchange:
NASDAQ
Full time employees:
59
Industry:
Biotechnology
Sector:
Healthcare
PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well as for the prevention of abdominal (soft tissue) SSIs. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.
18 Hasivim Street
Petah Tikva, 4959376
Petah Tikva, 4959376
CIK: 0001611842
ISIN: IL0011326795
CUSIP: M8001Q118
